\-\ Texto\\:\\ \ \(0\)\
\-\ lipase\\ 90\\.\\ normal\\ ast\\,\\ alt\\,\\ alkphos\\,\\ amylase\\.\ \(0\)\
\-\ the\\ patient\\ was\\ not\\ a\\ candidate\\ for\\ surgery\\ and\\ decided\\ to\\ undergo\\ chemotherapy\\ for\\ treatment\\.\ \(0\)\
\-\ large\\ heterogeneously\\ hypoattenuating\\ pancreatic\\ head\\ mass\\ \ \(0\)\
\-\ encasing\\ the\\ smv\\,\\ splenic\\ vein\\,\\ and\\ a\\ portion\\ of\\ the\\ portal\\ vein\\.\ \(0\)\
\-\ pancreatic\\ adenocarcinoma\ \(3\)\
\-\ \\â\\€\\¢\\ pancreatic\\ adenocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ chronic\\ \\ pancreatitis\ \(0\)\
\-\ \\â\\€\\¢\\ islet\\ cell\\ carcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ metastases\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ 65\\ y\\/o\\ woman\\ with\\ abdominal\\ pain\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pancreatic\\:\\ 0\\.1766530747494449\ \(0\)\
\-\ alkphos\\:\\ 0\\.11439959497755708\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1103531233518231\ \(0\)\
\-\ 90\\.\\:\\ 0\\.10463695863164237\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.10398744914262646\ \(0\)\
\-\ smv\\:\\ 0\\.09487432228572763\ \(0\)\
\-\ encasing\\:\\ 0\\.09038905846715672\ \(0\)\
\-\ vein\\:\\ 0\\.08709671329617232\ \(0\)\
\-\ islet\\:\\ 0\\.08699240977959492\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.0812816336090574\ \(0\)\
\-\ decided\\:\\ 0\\.07827354768936642\ \(0\)\
\-\ amylase\\:\\ 0\\.07408690651376175\ \(0\)\
\-\ candidate\\:\\ 0\\.07408690651376175\ \(0\)\
\-\ lipase\\:\\ 0\\.07369013359873787\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.07086378577532729\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.06603357801297756\ \(0\)\
\-\ ast\\:\\ 0\\.06536804442353325\ \(0\)\
\-\ alt\\:\\ 0\\.06536804442353325\ \(0\)\
\-\ splenic\\:\\ 0\\.06515300960478976\ \(0\)\
\-\ portal\\:\\ 0\\.06335253958352378\ \(0\)\
\-\ undergo\\:\\ 0\\.061101149429412555\ \(0\)\
\-\ 65\\:\\ 0\\.05874827499753699\ \(0\)\
\-\ metastases\\:\\ 0\\.051418766902013864\ \(0\)\
\-\ portion\\:\\ 0\\.04359445982195897\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.04314008148085726\ \(0\)\
\-\ lymphoma\\:\\ 0\\.034397163864640645\ \(0\)\
\-\ head\\:\\ 0\\.0341352297263929\ \(0\)\
\-\ carcinoma\\:\\ 0\\.034111657324167134\ \(0\)\
\-\ chronic\\:\\ 0\\.03390126243530986\ \(0\)\
\-\ y\\/o\\:\\ 0\\.03333280323689635\ \(0\)\
\-\ cell\\:\\ 0\\.03251043255748572\ \(0\)\
\-\ abdominal\\:\\ 0\\.030083369551015707\ \(0\)\
\-\ surgery\\:\\ 0\\.02922533893465176\ \(0\)\
\-\ woman\\:\\ 0\\.027801449964632484\ \(0\)\
\-\ large\\:\\ 0\\.026317499039874362\ \(0\)\
\-\ treatment\\:\\ 0\\.024360802247899816\ \(0\)\
\-\ for\\:\\ 0\\.020538257708245498\ \(0\)\
\-\ \\,\\:\\ 0\\.019064089120935733\ \(0\)\
\-\ normal\\:\\ 0\\.018867781050691566\ \(0\)\
\-\ not\\:\\ 0\\.01739181227805543\ \(0\)\
\-\ mass\\:\\ 0\\.016738887421796685\ \(0\)\
\-\ pain\\:\\ 0\\.014698706584939925\ \(0\)\
\-\ was\\:\\ 0\\.013919401721319533\ \(0\)\
\-\ patient\\:\\ 0\\.012064675083329408\ \(0\)\
\-\ a\\:\\ 0\\.011171825403340881\ \(0\)\
\-\ to\\:\\ 0\\.00601504378088713\ \(0\)\
\-\ the\\:\\ 0\\.0058415190719841885\ \(0\)\
\-\ and\\:\\ 0\\.00507067621780897\ \(0\)\
\-\ \\.\\:\\ 0\\.001999973864639227\ \(0\)\
\-\ with\\:\\ 0\\.0016479461421111232\ \(0\)\
\-\ of\\:\\ 0\\.0016408986027885695\ \(0\)\
